203
Views
31
CrossRef citations to date
0
Altmetric
Drug Evaluation

Daclizumab

&
Pages 1583-1596 | Published online: 05 Oct 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Divya Kandari & Rakesh Bhatnagar. (2023) Antibody engineering and its therapeutic applications. International Reviews of Immunology 42:2, pages 156-183.
Read now
Maya Campara, Ivo G Tzvetanov & Jose Oberholzer. (2010) Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation. Expert Opinion on Biological Therapy 10:6, pages 959-969.
Read now

Articles from other publishers (29)

Stefano Turolo, Alberto Edefonti, Marie Luise Syren & Giovanni Montini. (2023) Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation. Journal of Clinical Medicine 12:13, pages 4454.
Crossref
Maroun Abou-Jaoudé, Said El Hage, Dany Akiki & Rita Araman. (2021) Effect of donor-to-recipient HLA matching in low-immunological risk kidney transplant recipients without induction therapy on acute rejection, graft survival, infections, and surgical complications at 3 years: The road towards new recommendations. Transplant Immunology 69, pages 101490.
Crossref
Francisco Javier Candel, Marina Peñuelas, Carolina Tabares, Carolina Garcia-Vidal, Mayra Matesanz, Miguel Salavert, Pilar Rivas & Javier Pemán. (2020) Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies. Revista Iberoamericana de Micología 37:1, pages 5-16.
Crossref
Lidia Stork, Wolfgang Brück, Phillip von Gottberg, Ulrich Pulkowski, Florian Kirsten, Markus Glatzel, Sebastian Rauer, Franziska Scheibe, Helena Radbruch, Eckhard Hammer, Klarissa H Stürner, Barbara Kaulen, Christoph Heesen, Frank Hoffmann, Sebastian Brock, Marc Pawlitzki, Tobias Bopp & Imke Metz. (2019) Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosis. Multiple Sclerosis Journal 25:12, pages 1618-1632.
Crossref
Renumathy Dhanasekaran. (2017) Management of Immunosuppression in Liver Transplantation. Clinics in Liver Disease 21:2, pages 337-353.
Crossref
Josep M. Griny?Oriol Bestard. 2017. Kidney Transplantation, Bioengineering and Regeneration. Kidney Transplantation, Bioengineering and Regeneration 247 258 .
Carolyn D. Doucette, Anna L. Greenshields, Robert S. Liwski & David W. Hoskin. (2015) Piperine blocks interleukin-2-driven cell cycle progression in CTLL-2 T lymphocytes by inhibiting multiple signal transduction pathways. Toxicology Letters 234:1, pages 1-12.
Crossref
Joanna N. Hooten & Sarah A. Myers. 2015. Advances in Transplant Dermatology. Advances in Transplant Dermatology 1 17 .
Harsh Vardhan, Narayan Prasad, Akhilesh Jaiswal, Brijesh Yadav, Shashi Kumar, Dharmendra Bhadauria, Anupama Kaul, Amit Gupta, Anees Srivartava & Raj Kumar Sharma. (2014) Outcomes of living donor renal transplant recipients with and without basiliximab induction: A long-term follow-up study. Indian Journal of Transplantation 8:2, pages 44-50.
Crossref
Gianluigi Zaza, Paola Tomei, Simona Granata, Luigino Boschiero & Antonio Lupo. (2014) Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects. Toxins 6:3, pages 869-891.
Crossref
Boris Gala-Lopez, Andrew R. Pepper & A. M. James Shapiro. (2013) Biologic Agents in Islet Transplantation. Current Diabetes Reports 13:5, pages 713-722.
Crossref
Juan Almagro, Sreekumar Kodangattil & Jian Li. 2013. Making and Using Antibodies. Making and Using Antibodies 395 419 .
Rehiana Ali, Richard St John Nicholas & Paolo Antonio Muraro. (2013) Drugs in Development for Relapsing Multiple Sclerosis. Drugs 73:7, pages 625-650.
Crossref
Lin Wan, Shengyun Zhu, Jian Zhu, Hao Yang, Shengfu Li, Youping Li, Jingqiu Cheng & Xiaofeng Lu. (2012) Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris. Applied Microbiology and Biotechnology 97:9, pages 3855-3863.
Crossref
Kanwaljit K Chouhan. (2012) Antibody induction therapy in adult kidney transplantation: A controversy continues. World Journal of Transplantation 2:2, pages 19.
Crossref
Kimberly S Schluns. (2011) Window of opportunity for daclizumab. Nature Medicine 17:5, pages 545-547.
Crossref
Ian AC Rowe & James M Neuberger. 2011. Primer on Transplantation. Primer on Transplantation 18 34 .
Steven GabardiSpencer T. Martin, Keri L. RobertsMonica Grafals. (2011) Induction immunosuppressive therapies in renal transplantation. American Journal of Health-System Pharmacy 68:3, pages 211-218.
Crossref
Y Wang, V M Wang & C-C Chan. (2010) The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye 25:2, pages 127-139.
Crossref
Robert B Nussenblatt, Gordon Byrnes, H Nida Sen, Steven Yeh, Lisa Faia, Catherine Meyerle, Keith Wroblewski, Zhuqing Li, Baoying Liu, Emily Chew, Patti R Sherry, Penelope Friedman, Fred Gill & Frederick Ferris. (2010) A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATION. Retina 30:10, pages 1579-1587.
Crossref
Donald J. AbrahamWilliam J. Pitts. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 983 1063 .
Johan Fransson, Alexey Teplyakov, Gopalan Raghunathan, Ellen Chi, Wendy Cordier, Thai Dinh, Yiqing Feng, Jill Giles-Komar, Gary Gilliland, Bridget Lollo, Thomas J. Malia, Walter Nishioka, Galina Obmolova, Shanrong Zhao, Yonghong Zhao, Ronald V. Swanson & Juan C. Almagro. (2010) Human Framework Adaptation of a Mouse Anti-Human IL-13 Antibody. Journal of Molecular Biology 398:2, pages 214-231.
Crossref
Wagner L. Nedel, Dimitrios P. Kontoyiannis & Alessandro C. Pasqualotto. (2009) Aspergillosis in patients treated with monoclonal antibodies. Revista Iberoamericana de Micología 26:3, pages 175-183.
Crossref
Iqbal Grewal. 2009. Emerging Protein Biotherapeutics. Emerging Protein Biotherapeutics.
Maddalena Marasà & Jeffrey B. Kopp. (2009) Monoclonal antibodies for podocytopathies: rationale and clinical responses. Nature Reviews Nephrology 5:6, pages 337-348.
Crossref
Christian Toso, Ryan Edgar, Rena Pawlick, Juliet Emamaullee, Shaheed Merani, Parastoo Dinyari, Thomas F. Mueller, A. M. James Shapiro & Colin C. Anderson. (2009) Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transplant International 22:2, pages 182-191.
Crossref
Cecilia M. Choi, Alvin H. Schmaier, Michael R. Snell & Hillard M. Lazarus. (2009) Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation. Drugs 69:2, pages 183-198.
Crossref
Andrea A Zachary, Robert A Montgomery & Mary S Leffell. (2008) Defining unacceptable HLA antigens. Current Opinion in Organ Transplantation 13:4, pages 405-410.
Crossref
Shuzhong Guo, Yan Han, Xudong Zhang, Binglun Lu, Chenggang Yi, Hui Zhang, Xianjie Ma, Datai Wang, Li Yang, Xing Fan, Yunjing Liu, Kaihua Lu & Huiyuan Li. (2008) Human facial allotransplantation: a 2-year follow-up study. The Lancet 372:9639, pages 631-638.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.